Circassia Pharmaceuticals Plc - Product Pipeline Review - 2016

Published: Aug, 2016 | Pages: 38 | Publisher: Global Markets Direct
Industry: Pharmaceuticals & Healthcare | Report Format: Electronic (PDF)

Circassia Pharmaceuticals Plc - Product Pipeline Review - 2016

Summary

Global Markets Direct's, 'Circassia Pharmaceuticals Plc - Product Pipeline Review - 2016', provides an overview of the Circassia Pharmaceuticals Plc's pharmaceutical research and development focus. 

The report provides comprehensive information on the therapeutics under development by Circassia Pharmaceuticals Plc, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope

- The report provides a snapshot of the pipeline therapeutic landscape of Circassia Pharmaceuticals Plc
- The report provides overview of Circassia Pharmaceuticals Plc including its business description, key facts, and locations and subsidiaries
- The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities 
- The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages 
- The report assesses Circassia Pharmaceuticals Plc's pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type 
- The report features Circassia Pharmaceuticals Plc's out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects

Reasons To Buy

- Evaluate Circassia Pharmaceuticals Plc's strategic position with total access to detailed information on its product pipeline
- Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage 
- Identify and understand important and diverse types of therapeutics under development for Circassia Pharmaceuticals Plc
- Identify potential new clients or partners in the target demographic
- Plan mergers and acquisitions effectively by identifying key players and it's most promising pipeline therapeutics
- Devise corrective measures for pipeline projects by understanding Circassia Pharmaceuticals Plc's pipeline depth and focus of pipeline therapeutics
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

 Table of Contents

Table of Contents 2
List of Tables 4
List of Figures 4
Circassia Pharmaceuticals Plc Snapshot 5
Circassia Pharmaceuticals Plc Overview 5
Key Information 5
Key Facts 5
Circassia Pharmaceuticals Plc - Research and Development Overview 6
Key Therapeutic Areas 6
Circassia Pharmaceuticals Plc - Pipeline Review 9
Pipeline Products by Stage of Development 9
Pipeline Products - Monotherapy 10
Pipeline Products - Combination Treatment Modalities 11
Circassia Pharmaceuticals Plc - Pipeline Products Glance 12
Circassia Pharmaceuticals Plc - Late Stage Pipeline Products 12
Phase III Products/Combination Treatment Modalities 12
Circassia Pharmaceuticals Plc - Clinical Stage Pipeline Products 13
Phase II Products/Combination Treatment Modalities 13
Phase I Products/Combination Treatment Modalities 14
Circassia Pharmaceuticals Plc - Early Stage Pipeline Products 15
Preclinical Products/Combination Treatment Modalities 15
Circassia Pharmaceuticals Plc - Drug Profiles 16
Vaccine for Grass-Induced Rhinoconjunctivitis and Asthma 16
Product Description 16
Mechanism of Action 16
R&D Progress 16
glycopyrronium bromide 17
Product Description 17
Mechanism of Action 17
R&D Progress 17
Vaccine for Asthma and Ragweed-Induced Rhinoconjunctivitis 18
Product Description 18
Mechanism of Action 18
R&D Progress 18
Vaccine for Birch Pollen Allergy 20
Product Description 20
Mechanism of Action 20
R&D Progress 20
Vaccine for House Dust Mite Induced Allergic Rhinoconjunctivitis 21
Product Description 21
Mechanism of Action 21
R&D Progress 21
(fluticasone propionate + glycopyrronium bromide + salmeterol xinafoate) 22
Product Description 22
Mechanism of Action 22
R&D Progress 22
Vaccine for Japanese Cedar Pollen Allergy 23
Product Description 23
Mechanism of Action 23
R&D Progress 23
(Inhaled Corticosteroid + Long-acting Muscarinic Antagonist) 25
Product Description 25
Mechanism of Action 25
R&D Progress 25
(Long Acting Beta-2 Agonist + Long Acting Muscarinic Receptor Antagonist) 26
Product Description 26
Mechanism of Action 26
R&D Progress 26
Vaccine for Alternaria Allergy 27
Product Description 27
Mechanism of Action 27
R&D Progress 27
Circassia Pharmaceuticals Plc - Pipeline Analysis 28
Circassia Pharmaceuticals Plc - Pipeline Products by Target 28
Circassia Pharmaceuticals Plc - Pipeline Products by Route of Administration 29
Circassia Pharmaceuticals Plc - Pipeline Products by Molecule Type 30
Circassia Pharmaceuticals Plc - Pipeline Products by Mechanism of Action 31
Circassia Pharmaceuticals Plc - Recent Pipeline Updates 32
Circassia Pharmaceuticals Plc - Dormant Projects 35
Circassia Pharmaceuticals Plc - Locations And Subsidiaries 36
Head Office 36
Other Locations & Subsidiaries 36
Appendix 37
Methodology 37
Coverage 37
Secondary Research 37
Primary Research 37
Expert Panel Validation 37
Contact Us 37
Disclaimer 38

List of Tables

Circassia Pharmaceuticals Plc, Key Information 5
Circassia Pharmaceuticals Plc, Key Facts 5
Circassia Pharmaceuticals Plc - Pipeline by Indication, 2016 8
Circassia Pharmaceuticals Plc - Pipeline by Stage of Development, 2016 9
Circassia Pharmaceuticals Plc - Monotherapy Products in Pipeline, 2016 10
Circassia Pharmaceuticals Plc - Combination Treatment Modalities in Pipeline, 2016 11
Circassia Pharmaceuticals Plc - Phase III, 2016 12
Circassia Pharmaceuticals Plc - Phase II, 2016 13
Circassia Pharmaceuticals Plc - Phase I, 2016 14
Circassia Pharmaceuticals Plc - Preclinical, 2016 15
Circassia Pharmaceuticals Plc - Pipeline by Target, 2016 28
Circassia Pharmaceuticals Plc - Pipeline by Route of Administration, 2016 29
Circassia Pharmaceuticals Plc - Pipeline by Molecule Type, 2016 30
Circassia Pharmaceuticals Plc - Pipeline Products by Mechanism of Action, 2016 31
Circassia Pharmaceuticals Plc - Recent Pipeline Updates, 2016 32
Circassia Pharmaceuticals Plc - Dormant Developmental Projects,2016 35
Circassia Pharmaceuticals Plc, Subsidiaries 36